LumiThera
Poulsbo
About LumiThera
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. The company is developing solutions to prevent vision loss and blindness, improve visual function, and stop or slow the progression of blinding diseases of the eye. They delivering photobiomodulation (PBM) treatment for ocular disorders and diseases. LumiThera also focused on treating patients affected by dry age-related macular degeneration. The company’s expertise is in the application of photobiomodulation (PBM), using non-invasive light-emitting diodes (LED) for acute and chronic ocular diseases and disorders. The company was founded in 2013 and is headquartered in Poulsbo, Washington, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $38.9M
- Funding stage: M&A
- Last round: Series Unknown (May 2024)
- Website: lumithera.com
- Phone: +44-2076601516
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lumithera-68730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.